Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析

◆英語タイトル:Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15780
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Corcept Therapeutics Inc (CORT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Corcept Therapeutics Inc (Corcept) is a research focused pharmaceutical company which discovers, develops and commercializes innovative therapeutics in the areas of psychiatric and metabolic diseases. The company focuses on developing drugs for the treatment of severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol. Corcept’s lead product candidate Korlym (mifepristone) is the first drug candidate to be approved for the treatment of patients with Cushing’s syndrome. Other products in the pipeline include mifepristone for psychotic depression; CORT 108297 and other GR antagonists that help in the prevention of antipsychotic-induced weight gain mitigation. Corcept is headquartered in Menlo Park, California, the US.

Corcept Therapeutics Inc Key Recent Developments

Mar 18,2019 Corcept Therapeutics names Andreas Grauer, M.D., as chief medical officer
Feb 25,2019 Corcept Therapeutics announces fourth quarter and full-year 2018 audited financial results and provides corporate update
Feb 05,2019 Kaplan Fox investigates Corcept Therapeutics
Jan 31,2019 Corcept Therapeutics announces fourth quarter and full-year 2018 preliminary selected financial results; provides 2019 revenue guidance

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Corcept Therapeutics Inc – Key Facts
Corcept Therapeutics Inc – Key Employees
Corcept Therapeutics Inc – Key Employee Biographies
Corcept Therapeutics Inc – Major Products and Services
Corcept Therapeutics Inc – History
Corcept Therapeutics Inc – Company Statement
Corcept Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Corcept Therapeutics Inc – Business Description
Corcept Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Corcept Therapeutics Inc – Strengths
Corcept Therapeutics Inc – Weaknesses
Corcept Therapeutics Inc – Opportunities
Corcept Therapeutics Inc – Threats
Corcept Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Corcept Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 18, 2019: Corcept Therapeutics names Andreas Grauer, M.D., as chief medical officer
Feb 25, 2019: Corcept Therapeutics announces fourth quarter and full-year 2018 audited financial results and provides corporate update
Feb 05, 2019: Kaplan Fox investigates Corcept Therapeutics
Jan 31, 2019: Corcept Therapeutics announces fourth quarter and full-year 2018 preliminary selected financial results; provides 2019 revenue guidance
Nov 01, 2018: Corcept Therapeutics announces third quarter 2018 financial results and provides corporate update
Aug 09, 2018: Corcept Therapeutics announces second quarter 2018 financial results and stock repurchase program; Provides clinical update
May 08, 2018: Corcept Therapeutics Announces First Quarter 2018 Financial results and Provides Corporate Update
Feb 22, 2018: Corcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial
Feb 01, 2018: Corcept Therapeutics Announces Fourth Quarter and Full-Year 2017 Preliminary Selected Financial Results; Provides 2018 Revenue Guidance
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Corcept Therapeutics Inc, Key Facts
Corcept Therapeutics Inc, Key Employees
Corcept Therapeutics Inc, Key Employee Biographies
Corcept Therapeutics Inc, Major Products and Services
Corcept Therapeutics Inc, History
Corcept Therapeutics Inc, Subsidiaries
Corcept Therapeutics Inc, Key Competitors
Corcept Therapeutics Inc, Ratios based on current share price
Corcept Therapeutics Inc, Annual Ratios
Corcept Therapeutics Inc, Annual Ratios (Cont...1)
Corcept Therapeutics Inc, Annual Ratios (Cont...2)
Corcept Therapeutics Inc, Interim Ratios
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Corcept Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Corcept Therapeutics Inc, Performance Chart (2014 - 2018)
Corcept Therapeutics Inc, Ratio Charts
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GfK SE:企業の戦略・SWOT・財務分析
    SummaryGfK SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - Detai …
  • Australian Agricultural Company Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Australian Agricultural Company …
  • Petron Malaysia Refining & Marketing Bhd (PETRONM):企業の財務及び戦略的SWOT分析
    Summary Petron Malaysia Refining & Marketing Bhd (Petron Malaysia) a subsidiary of Exxon Mobil Corporation is an oil and gas service provider. The company manufactures and sells petroleum products. Its products include retail fuels, automotive lubricants, liquefied petroleum gas, commercial fuels, i …
  • Suda Ltd (SUD):企業概要、財務及び戦略的SWOT分析
    Summary Suda Ltd (Suda) is a drug delivery company. The company develops and markets oro-mucosal drug delivery technology for development of pharmaceuticals. Its products include ArTiMist, SUD-001, SUD-002, SUD-003, SUD-004 and SUD-005. Suda’s ArTiMist is a sub-lingual spray for the treatment of p. …
  • Abengoa, S.A. (ABG)(エネルギー分野):企業M&A動向
    Summary Abengoa, S.A. (Abengoa) is a technology company that provides solutions for the sustainable development of environment, and energy sectors, generating electricity from the sun, desalinating sea water, producing biofuels and recycling industrial waste. The company operates through three busin …
  • Nezavisni operator sustava u Bosni i Hercegovini:企業の戦略的SWOT分析
    Nezavisni operator sustava u Bosni i Hercegovini - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • CyberOptics Corporation (CYBE):企業の財務及び戦略的SWOT分析
    Summary CyberOptics Corporation (CyberOptics) is an electronic equipment company that provides sensing technology solutions. The company offers SMT inspection, semiconductor and MRS sensor products. Its SMT inspection products offer solder paste inspection systems, automated optical inspection syste …
  • CCM Duopharma Biotech Bhd (CCMDBIO):企業財務及び戦略的SWOT分析
    Summary CCM Duopharma Biotech Bhd (CCM Duopharma), a subsidiary of Chemical Company of Malaysia Bhd is an investment holding company that manufactures, distributes, imports and exports generic and over-the-counter pharmaceutical products. The company offers products such as tablets, capsules, syrup, …
  • Volvo Technology Transfer Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Volvo Technology Transfer Corpo …
  • Commercial Metals Co:戦略・SWOT・企業財務分析
    Commercial Metals Co - Strategy, SWOT and Corporate Finance Report Summary Commercial Metals Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • CKE Restaurants, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CKE Restaurants, Inc. Mergers a …
  • Akorn Inc (AKRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Akorn Inc (Akorn) develops, manufactures, and commercializes generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal health pharmaceuticals. The company offers its products in both sterile and non-sterile dosage forms including or …
  • Sino-Ocean Land Holdings Limited:企業の戦略・SWOT・財務分析
    SummarySino-Ocean Land Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the com …
  • Irkut Corporation (IRKT):企業の財務・戦略的SWOT分析
    Irkut Corporation (IRKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • China All Access (Holdings) Limited (633):企業財務及び戦略的SWOT分析
    Summary China All Access (Holdings) Limited (CAA) is a technology service provider that offers communication services. The company provides smart technology-based complete information communication solutions and services. It offers information communication solutions that support satellite networks. …
  • Charles River Laboratories International Inc (CRL):製薬・医療:M&Aディール及び事業提携情報
    Summary Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. Th …
  • TFP Solutions Berhad (TFP):企業概要、財務及び戦略的SWOT分析
    Summary TFP Solutions Berhad (TFP Solutions) is an information technology company. The company develops and offers software solutions and services. It provides business management and converged infrastructure solutions. TFP Solutions offers converged infrastructure solutions such as enterprise serve …
  • Esso SAF (ES):企業財務及び戦略的SWOT分析
    Summary Esso SAF (Esso), a subsidiary of Exxon Mobil Corporation is a fuel distribution company that offers refining and distribution of petroleum products. The company purchases, refines and markets crude oil, fuels and other finished products. It supplies products such as fuels, cards, aviation fu …
  • Create Medic Co., Ltd. (5187):企業の財務及び戦略的SWOT分析
    Summary Create Medic Co., Ltd. (Create Medic) is a medical device company that discovers, manufactures and sells medical appliances. The company’s product categories include urinary drainage, PEG related products, endoscopic products, intestinal treatment devices, anesthesiology products and IVR dev …
  • Oncodesign SA:製品開発パイプライン動向2015
    Oncodesign SA - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Oncodesign SA - Product Pipeline Review - 2015’, provides an overview of the Oncodesign SA’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic devel …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆